BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 34948438)

  • 1. Prothrombotic Phenotype in COVID-19: Focus on Platelets.
    Barale C; Melchionda E; Morotti A; Russo I
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.
    Grobler C; Maphumulo SC; Grobbelaar LM; Bredenkamp JC; Laubscher GJ; Lourens PJ; Steenkamp J; Kell DB; Pretorius E
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelets and COVID-19.
    Rohlfing AK; Rath D; Geisler T; Gawaz M
    Hamostaseologie; 2021 Oct; 41(5):379-385. PubMed ID: 34695854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of COVID-19 Disease on Platelets and Coagulation.
    Wool GD; Miller JL
    Pathobiology; 2021; 88(1):15-27. PubMed ID: 33049751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
    D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
    World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.
    Smadja DM; Mentzer SJ; Fontenay M; Laffan MA; Ackermann M; Helms J; Jonigk D; Chocron R; Pier GB; Gendron N; Pons S; Diehl JL; Margadant C; Guerin C; Huijbers EJM; Philippe A; Chapuis N; Nowak-Sliwinska P; Karagiannidis C; Sanchez O; Kümpers P; Skurnik D; Randi AM; Griffioen AW
    Angiogenesis; 2021 Nov; 24(4):755-788. PubMed ID: 34184164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy.
    Nicolai L; Leunig A; Brambs S; Kaiser R; Weinberger T; Weigand M; Muenchhoff M; Hellmuth JC; Ledderose S; Schulz H; Scherer C; Rudelius M; Zoller M; Höchter D; Keppler O; Teupser D; Zwißler B; von Bergwelt-Baildon M; Kääb S; Massberg S; Pekayvaz K; Stark K
    Circulation; 2020 Sep; 142(12):1176-1189. PubMed ID: 32755393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis.
    Gando S; Wada T
    Shock; 2022 Jan; 57(1):1-6. PubMed ID: 34172612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-Mediated Platelet Activation in COVID-19 and Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    Uzun G; Pelzl L; Singh A; Bakchoul T
    Front Immunol; 2022; 13():837629. PubMed ID: 35273612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of immunothrombosis in COVID-19.
    Portier I; Campbell RA; Denorme F
    Curr Opin Hematol; 2021 Nov; 28(6):445-453. PubMed ID: 34232139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic Complications of COVID-19 Infection: A Review.
    Castro RA; Frishman WH
    Cardiol Rev; 2021; 29(1):43-47. PubMed ID: 32947478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
    Drews RE
    Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia.
    Iba T; Levy JH
    Trends Cardiovasc Med; 2022 Jan; 32(1):1-9. PubMed ID: 34455073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets: "multiple choice" effectors in the immune response and their implication in COVID-19 thromboinflammatory process.
    Rolla R; Puricelli C; Bertoni A; Boggio E; Gigliotti CL; Chiocchetti A; Cappellano G; Dianzani U
    Int J Lab Hematol; 2021 Oct; 43(5):895-906. PubMed ID: 33749995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet Activation and Thrombosis in COVID-19.
    Iba T; Wada H; Levy JH
    Semin Thromb Hemost; 2023 Feb; 49(1):55-61. PubMed ID: 35738296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs.
    Won T; Wood MK; Hughes DM; Talor MV; Ma Z; Schneider J; Skinner JT; Asady B; Goerlich E; Halushka MK; Hays AG; Kim DH; Parikh CR; Rosenberg AZ; Coppens I; Johns RA; Gilotra NA; Hooper JE; Pekosz A; Čiháková D
    EBioMedicine; 2022 Jan; 75():103812. PubMed ID: 35033854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Janus Kinase Signaling Pathway and Its Role in COVID-19 Inflammatory, Vascular, and Thrombotic Manifestations.
    Ravid JD; Leiva O; Chitalia VC
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets and SARS-CoV-2 During COVID-19: Immunity, Thrombosis, and Beyond.
    Sciaudone A; Corkrey H; Humphries F; Koupenova M
    Circ Res; 2023 May; 132(10):1272-1289. PubMed ID: 37167360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases.
    Acanfora D; Acanfora C; Ciccone MM; Scicchitano P; Bortone AS; Uguccioni M; Casucci G
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.